The global capital of entrepreneurship last week was….Buffalo, N.Y. As part of a billion-dollar initiative to kickstart the western New York economy, Buffalo hosted the biggest pitchcontest ever: $5 million, doled out to 11 startups last Thursday, ... Forbes.com, 1 month ago
2 images for "harvard bone marrow initiative"
MS Research Highlights in 2014 Offer New Leads in Stopping MS, Restoring Function Lost, and Ending MS Forever
In 2014, the National Multiple Sclerosis Society invested $50.6 million in 380 new and ongoing research projects and initiatives. Here is a brief summary of the research highlights reflecting the Society's commitment to pursue promising ...Red Orbit, 3 weeks ago MS Research Highlights In 2014 That Offer New Leads In Stopping MS, Restoring Function Lost, And Ending MS Forever Pharmacy Times, 2 weeks ago
Valeo, Tom Back to Top | Article Outline ARTICLE IN BRIEF A research team developed a mouse model of the JC virus, which suggests that the virus multiplies primarily in astrocytes, rather than oligodendrocytes. Neuroinfectious disease experts ...Neurology Today, 1 week ago
UPMC/University of Pittsburgh Schools of the Health Sciences PITTSBURGH, Dec. 17, 2014 - Warren Shlomchik, M.D., a leading expert in investigating the immunologic mechanisms underlying graft-versus-host-disease (GVHD), a common complication for some ...Noodls, 1 week ago
New Follow-Up Data for IMBRUVICA® (ibrutinib) Presented at ASH Show Longer Term Efficacy in Patients with..
/PRNewswire/ -- Data confirms consistency of IMBRUVICA as an effective treatment option for patients with these challenging blood cancers Note: This press release corresponds to ASH abstracts 3331 and 4453 Janssen-Cilag International NV ...ADVFN India, 2 weeks ago
More from: , Sys-Con Australia...and 1 other sources
PUBLIC RELEASE DATE: 7-Dec-2014 Although it is among the most highly metastatic of all cancers, multiple myeloma is driven to spread by only a subset of the myeloma cells within a patient's body, researchers at Dana-Farber Cancer Institute have ...EurekAlert!, 2 weeks ago
Original Article Stephen M. Ansell, M.D., Ph.D., Alexander M. Lesokhin, M.D., Ivan Borrello, M.D., Ahmad Halwani, M.D., Emma C. Scott, M.D., Martin Gutierrez, M.D., Stephen J. Schuster, M.D., Michael M. Millenson, M.D., Deepika Cattry, M.S., ...New England Journal of Medicine, 2 weeks ago
Published: December 5, 2014. Location, location, location goes the old real estate proverb but cancer also responds to its neighborhood, particularly in the physical surroundings of bone marrow cells where human myeloid leukemias arise and ...ScienceNewsline, 3 weeks ago
Stemline Therapeutics Announces Multiple Preclinical Presentations Highlighting Its Pipeline of IL-3R-Directed Therapeutics at the American Society of Hematology (ASH) Annual Meeting
NEW YORK, Dec. 5, 2014 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. ( Nasdaq:STML ), announced today that results from multiple ongoing preclinical studies were selected for presentation at the 2014 American Society of Hematology (ASH) Annual ...Reliance Trust, 3 weeks ago Stemline Therapeutics, Inc. Announces Multiple Preclinical Presentations Highlighting Its Pipeline Of IL-3R-Directed Therapeutics At The American Society of Hematology Annual Meeting BioSpace, 3 weeks ago STEMLINE THERAPEUTICS : Announces Multiple Preclinical Presentations Highlighting Its Pipeline of IL-3R-Directed Therapeutics at the American Society of Hematology (ASH) Annual Meeting 4 Traders, 3 weeks ago
Image Tools A new retrospective cohort study has for the first time defined the clinical course of light-chain smoldering multiple myeloma—i.e., the disease stage preceding light-chain multiple myeloma. A subset of patients with idiopathic ...Oncology Times, 3 weeks ago ONLINE FIRST: Missing Piece of Myeloma Puzzle Defined Oncology Times, 1 month ago
on your WebpageAdd Widget >Get your members hooked!